SCHEMBL581812

SCHEMBL581812

CC(C)(C)c1cccc(B2OC(C)(C)C(C)(C)O2)c1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 14/20 0.49
LPL P06858 13/20 0.49
HIF1A Q16665 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
KIF11 P52732 1/20 0.36
FFAR1 O14842 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29560947 1.00 LIPG (0.49) LIPGLPLHIF1AIRAK4HDAC4
SCHEMBL15600538 0.88 LIPG (0.45) LIPGLPLHIF1AIRAK4HDAC4
SCHEMBL23831098 0.86 LIPG (0.50) LIPGLPLHIF1AIRAK4CA1
SCHEMBL2299910 0.86 LIPG (0.47) LIPGLPLHIF1AIRAK4FFAR1
SCHEMBL12005587 0.86 LIPG (0.47) LIPGLPLHIF1AIRAK4FFAR1
SCHEMBL4427545 0.86 LIPG (0.47) LIPGLPLHIF1AIRAK4FFAR1
Hydrochloric Acid SCHEMBL15845966 0.85 LIPG (0.46) LIPGLPLHIF1AIRAK4FFAR1
SCHEMBL10248 0.84 LPL (0.48) LIPGLPLIRAK4
SCHEMBL19280284 0.83 LIPG (0.44) LIPGLPLHIF1AIRAK4FFAR1
SCHEMBL15191545 0.83 LIPG (0.44) LIPGLPLHIF1AIRAK4FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4351302-B1 LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC EQUIPMENT INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND SAMSUNG DISPLAY CO LTD (KR) 2026-04-29 EP disclosed
US-12310233-B2 Development of material for hole blocking layer with high efficiency and long lifespan, and organic light-emitting device and electronic apparatus utilizing the same SAMSUNG DISPLAY CO., LTD. (KR) 2025-05-20 US disclosed
US-20240155860-A1 LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC EQUIPMENT INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2024-05-09 US disclosed
EP-4351302-A1 LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC EQUIPMENT INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND Samsung Display Co., Ltd. (KR) 2024-04-10 EP disclosed
CN-117858600-A Condensed-cyclic compound, and light-emitting device, electronic device, and electronic apparatus including the same 三星显示有限公司 2024-04-09 CN disclosed
US-20240081145-A1 DEVELOPMENT OF MATERIAL FOR HOLE BLOCKING LAYER WITH HIGH EFFICIENCY AND LONG LIFESPAN, AND ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS UTILIZING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-03-07 US disclosed
US-20240025933-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2024-01-25 US disclosed
US-11818947-B2 Development of material for hole blocking layer with high efficiency and long lifespan, and organic light-emitting device and electronic apparatus utilizing the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-14 US disclosed
US-11818947-B2 Development of material for hole blocking layer with high efficiency and long lifespan, and organic light-emitting device and electronic apparatus utilizing the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-14 US disclosed
US-11818947-B2 Development of material for hole blocking layer with high efficiency and long lifespan, and organic light-emitting device and electronic apparatus utilizing the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-14 US disclosed
EP-2417131-A1 ISOXAZOL-3(2H)-ONE ANALOGS AS THERAPEUTIC AGENTS AstraZeneca AB (SE) 2012-02-15 EP disclosed
WO-2010117323-A1 METHOD AND APPARATUS FOR PRODUCING HEAT ENERGY AND CARBON DIOXIDE ASTRAZENECA AB (SE) 2010-10-14 WO disclosed
US-20100261755-A1 ISOXAZOL-3(2H)-ONE ANALOGS AS THERAPEUTIC AGENTS ASTRAZENECA AB (SE) 2010-10-14 US disclosed
US-20100163852-A1 Material for light-emitting device and light-emitting device TORAY INDUSTRIES, INC. (JP) 2010-07-01 US disclosed
EP-2028249-A1 MATERIAL FOR LIGHT-EMITTING DEVICE, AND LIGHT-EMITTING DEVICE Toray Industries, Inc. (JP) 2009-02-25 EP disclosed
EP-1506190-B1 (IMIDAZOL-1-YL-METHYL)-PYRIDAZINE AS NMDA RECEPTOR BLOCKER HOFFMANN LA ROCHE (CH) 2006-06-14 EP disclosed
US-7005432-B2 Substituted imidazol-pyridazine derivatives HOFFMAN-LA ROCHE INC. (US) 2006-02-28 US disclosed
EP-1506190-A1 (IMIDAZOL-1-YL-METHYL)-PYRIDAZINE AS NMDA RECEPTOR BLOCKER F. HOFFMANN-LA ROCHE AG (CH) 2005-02-16 EP disclosed
US-20030229096-A1 Substituted imidazol-pyridazine derivatives EVOTEC INTERNATIONAL GMBH (DE) 2003-12-11 US disclosed
WO-2003097637-A1 (IMIDAZOL-1-YL-METHYL)-PYRIDAZINE AS NMDA RECEPTOR BLOCKER F. HOFFMANN-LA ROCHE AG (CH) 2003-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11818947-B2 Development of material for hole blocking layer with high efficiency and long lifespan, and organic light-emitting device and electronic apparatus utilizing the same PER2, CYBA, CRY2 LIPG 2364/4885LPL 847/4885HIF1A 3164/4885
US-12310233-B2 Development of material for hole blocking layer with high efficiency and long lifespan, and organic light-emitting device and electronic apparatus utilizing the same PER2, CYBA, CRY2 LIPG 2364/4885LPL 847/4885HIF1A 3164/4885
US-20240025933-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME ODC1, OXA1L, LRRK2 LIPG 4730/4885LPL 4135/4885HIF1A 3362/4885
US-20030229096-A1 Substituted imidazol-pyridazine derivatives GRIN2B, GRIN2A, GRIN2C LIPG 4808/4885LPL 4626/4885HIF1A 1341/4885
US-20100163852-A1 Material for light-emitting device and light-emitting device CRY1, CRY2, S100A10 LIPG 3475/4885LPL 875/4885HIF1A 2443/4885
US-20240081145-A1 DEVELOPMENT OF MATERIAL FOR HOLE BLOCKING LAYER WITH HIGH EFFICIENCY AND LONG LIFESPAN, AND ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS UTILIZING THE SAME PER2, CYBA, CRY2 LIPG 2364/4885LPL 847/4885HIF1A 3164/4885
US-20100261755-A1 ISOXAZOL-3(2H)-ONE ANALOGS AS THERAPEUTIC AGENTS NR4A3, CBR3, OXER1 LIPG 4757/4885LPL 4511/4885HIF1A 2225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.